Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

It might feel like your world stops after receiving a diagnosis of breast or ovarian cancer. Even in that mental and emotional fog, there are several next steps to consider. Coming up with a treatment ...

Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...

Cirtuvivint is a selective pan-CLK, pan-DYRK inhibitor that modulates alternative RNA splicing, including transcripts involved in oncogenic pathways. Preclinical studies have shown that CLK/DYRK ...

This study came out of a multi-institutional collaboration called the BRCA BCY group, which is an international group of ...

Use of MHT following menopause is not associated with an increased risk for breast cancer among BRCA1 and BRCA2 carriers.

Lindsay Avner gave birth to her daughter last month. Lindsay Avner used IVF to ensure her daughter would not carry a BRCA gene mutation. She's seen here with her husband and step-children. Laura ...

Forbes contributors publish independent expert analyses and insights. I cover cancer science, treatments and attitudes. The problem – what’s really a double-question – is knowing how high is the risk ...

Three studies examine how resistance to chemotherapy develops in cancers deficient in BRCA1 and BRCA2. The mechanism involves restoration of BRCA1 and BRCA2 activity. Shah examines the implications ...

Other studies, too, have reported an uptick in BRCA testing after Jolie’s announcement — the “Angelina effect” — but this one went further. Although insurance claims for nearly 10 million women aged ...

The announcement by Health Secretary Wes Streeting that the NHS Jewish BRCA Testing Programme is to be restarted next year is welcome news. Most importantly, it will come as a great relief for anyone ...